Alpha Tau Medical Ltd.

NasdaqCM DRTS

Alpha Tau Medical Ltd. Free Cash Flow Per Share for the year ending December 31, 2023: USD -0.35

Alpha Tau Medical Ltd. Free Cash Flow Per Share is USD -0.35 for the year ending December 31, 2023, a 9.99% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.

Alpha Tau Medical Ltd. Free Cash Flow Per Share for the year ending December 31, 2022 was USD -0.39, a -7.26% change year over year.
Alpha Tau Medical Ltd. Free Cash Flow Per Share for the year ending December 31, 2021 was USD -0.36, a -33.46% change year over year.
Alpha Tau Medical Ltd. Free Cash Flow Per Share for the year ending December 31, 2020 was USD -0.27, a -124.63% change year over year.
Alpha Tau Medical Ltd. Free Cash Flow Per Share for the year ending December 31, 2019 was USD -0.12.

Key data

Date	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)

NasdaqCM: DRTS

Alpha Tau Medical Ltd.

CEO	Mr. Uzi Sofer
IPO Date	March 8, 2021
Location	Israel
Headquarters	5 Kiryat Hamada Street
Employees	121
Sector	Healthcare
Industries Biotechnology 3D Printing Clinical Trials Pharmaceuticals

Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Key trends

Past 5 years